搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
uthr
/
财务摘要
United Therapeutics Corp
UTHR
添加自选
500.350
USD
-2.350
-0.47%
收盘 09-15 16:00(美东)
21.35B
总市值
17.09
市盈率 TTM
United Therapeutics Corp
500.350
-2.350
-0.47%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
UTHR 财务数据
通过专为投资者打造的一站式数据看板,全面查看 United Therapeutics Corp 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
21.35B
股息TTM
0.00
市盈率 TTM
17.09
每股收益TTM
29.27
营业收入
3.18B
净利润
1.20B
净资产收益率
20.26%
总资产收益率
17.81%
United Therapeutics Corp 财报日历
最新发布
8月 5, 2026
每股收益 / 预测值
7.82
/6.83
营业收入 / 预测值
783.30M
/805.65M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
13.91%
7.82
-11.93%
6.32
25.09%
8.39
11.58%
7.73
9.56%
6.86
10.00%
7.18
45.58%
6.71
21.46%
6.93
13.33%
6.26
25.38%
6.52
60.86%
4.61
--
5.71
--
5.53
--
5.20
--
2.87
--
13.14
--
--
--
--
--
--
--
--
营业收入
-1.92%
783.30M
-1.62%
781.50M
7.38%
790.20M
6.76%
799.50M
11.71%
798.60M
17.22%
794.40M
19.72%
735.90M
22.89%
748.90M
19.85%
714.90M
33.70%
677.70M
25.07%
614.70M
18.10%
609.40M
27.76%
596.50M
9.74%
506.90M
18.38%
491.50M
16.03%
516.00M
4.57%
466.90M
21.84%
461.90M
7.87%
415.20M
17.00%
444.70M
净利润
7.59%
333.00M
-14.68%
274.90M
20.91%
364.30M
9.58%
338.70M
11.29%
309.50M
5.09%
322.20M
38.78%
301.30M
15.51%
309.10M
7.29%
278.10M
27.27%
306.60M
64.35%
217.10M
11.83%
267.60M
123.45%
259.20M
0.42%
240.90M
17.74%
132.10M
47.08%
239.30M
-32.79%
116.00M
747.70%
239.90M
13.56%
112.20M
-4.96%
162.70M
利润率
9.69%
42.51%
-13.27%
35.18%
12.60%
46.10%
2.64%
42.36%
-0.37%
38.76%
-10.35%
40.56%
15.93%
40.94%
-6.01%
41.27%
-10.48%
38.90%
-4.80%
45.24%
31.41%
35.32%
--
43.91%
--
43.45%
--
47.52%
--
26.88%
--
41.20%
--
--
--
--
--
--
--
--
毛利率
-1.95%
87.30%
-6.14%
82.93%
-3.09%
86.91%
-1.71%
87.38%
-0.10%
89.03%
-0.99%
88.36%
1.40%
89.69%
0.46%
88.90%
-0.15%
89.12%
-0.49%
89.24%
0.47%
88.45%
--
88.50%
--
89.25%
--
89.68%
--
88.04%
--
93.58%
--
--
--
--
--
--
--
--
资产负债率
--
--
-100.00%
0.00%
-100.00%
0.00%
-100.00%
0.00%
-100.00%
0.00%
-72.04%
2.58%
-58.29%
4.07%
-50.70%
5.62%
-37.89%
7.44%
-26.72%
9.24%
-26.20%
9.77%
--
11.39%
--
11.97%
--
12.61%
--
13.24%
--
13.84%
--
--
--
--
--
--
--
--
利润表
营业收入
-1.92%
783.30M
-1.62%
781.50M
7.38%
790.20M
6.76%
799.50M
11.71%
798.60M
17.22%
794.40M
19.72%
735.90M
22.89%
748.90M
19.85%
714.90M
33.70%
677.70M
25.07%
614.70M
18.10%
609.40M
27.76%
596.50M
9.74%
506.90M
18.38%
491.50M
16.03%
516.00M
4.57%
466.90M
21.84%
461.90M
7.87%
415.20M
17.00%
444.70M
营业利润
-14.34%
330.80M
-14.89%
325.80M
-1.70%
357.50M
-4.63%
389.30M
20.73%
386.20M
7.44%
382.80M
37.92%
363.70M
24.83%
408.20M
2.07%
319.90M
25.28%
356.30M
41.17%
263.70M
4.04%
327.00M
55.30%
313.40M
-1.25%
284.40M
9.37%
186.80M
36.71%
314.30M
-9.18%
201.80M
339.02%
288.00M
161.56%
170.80M
3.98%
229.90M
净利润
7.59%
333.00M
-14.68%
274.90M
20.91%
364.30M
9.58%
338.70M
11.29%
309.50M
5.09%
322.20M
38.78%
301.30M
15.51%
309.10M
7.29%
278.10M
27.27%
306.60M
64.35%
217.10M
11.83%
267.60M
123.45%
259.20M
0.42%
240.90M
17.74%
132.10M
47.08%
239.30M
-32.79%
116.00M
747.70%
239.90M
13.56%
112.20M
-4.96%
162.70M
资产负债表
流动资产
-8.97%
3.48B
-27.10%
2.87B
-4.42%
3.70B
-12.66%
3.49B
5.73%
3.83B
21.27%
3.94B
9.09%
3.87B
15.66%
4.00B
12.64%
3.62B
1.74%
3.25B
5.05%
3.55B
13.17%
3.46B
19.71%
3.21B
23.44%
3.19B
45.48%
3.38B
28.10%
3.06B
15.81%
2.68B
28.41%
2.59B
7.22%
2.32B
27.71%
2.39B
流动负债总额
15.31%
607.80M
-16.96%
599.10M
-24.05%
560.60M
-37.45%
546.30M
-36.67%
527.10M
-16.16%
721.50M
-8.24%
738.10M
17.38%
873.40M
124.76%
832.30M
165.13%
860.60M
134.38%
804.40M
135.55%
744.10M
11.70%
370.30M
10.94%
324.60M
12.38%
343.20M
-1.28%
315.90M
6.45%
331.50M
-3.24%
292.60M
-5.54%
305.40M
23.60%
320.00M
总资产
-8.70%
7.22B
-13.30%
6.71B
7.01%
7.88B
3.20%
7.35B
17.62%
7.91B
19.22%
7.74B
2.75%
7.36B
1.42%
7.12B
0.63%
6.72B
2.35%
6.50B
18.57%
7.17B
21.48%
7.02B
20.53%
6.68B
18.40%
6.35B
16.94%
6.04B
14.51%
5.78B
14.42%
5.54B
15.49%
5.36B
12.01%
5.17B
14.46%
5.05B
总负债
11.63%
819.80M
-13.20%
813.10M
-14.80%
783.80M
-25.56%
760.90M
-28.42%
734.40M
-19.05%
936.70M
-22.18%
920.00M
-22.06%
1.02B
-19.23%
1.03B
-5.37%
1.16B
-5.26%
1.18B
7.55%
1.31B
3.71%
1.27B
3.32%
1.22B
3.11%
1.25B
0.02%
1.22B
1.62%
1.22B
-1.01%
1.18B
-0.79%
1.21B
8.08%
1.22B
总权益
-10.78%
6.40B
-13.31%
5.90B
10.12%
7.10B
8.02%
6.59B
25.91%
7.17B
27.52%
6.81B
7.67%
6.44B
6.81%
6.10B
5.29%
5.70B
4.19%
5.34B
24.77%
5.98B
25.20%
5.71B
25.30%
5.41B
22.67%
5.12B
21.16%
4.80B
19.13%
4.56B
18.65%
4.32B
21.21%
4.18B
16.60%
3.96B
16.65%
3.83B
现金流量表
经营净额
63.59%
313.60M
0.46%
463.30M
1.47%
346.20M
49.02%
562.10M
-17.44%
191.70M
22.50%
461.20M
126.41%
341.20M
8.95%
377.20M
118.44%
232.20M
0.45%
376.50M
17.55%
150.70M
33.87%
346.20M
-16.30%
106.30M
29.82%
374.80M
-26.58%
128.20M
39.33%
258.60M
-14.30%
127.00M
221.49%
288.70M
38.35%
174.60M
-26.03%
185.60M
投资净额
129.18%
87.50M
551.55%
743.70M
-84.74%
-227.60M
222.63%
140.90M
-274.88%
-299.90M
-122.40%
-164.70M
-392.64%
-123.20M
63.34%
-114.90M
64.79%
-80.00M
432.56%
735.30M
122.24%
42.10M
-233.40%
-313.40M
-34.44%
-227.20M
38.45%
-221.10M
3.32%
-189.30M
60.15%
-94.00M
-245.60%
-169.00M
-5601.59%
-359.20M
-206.90%
-195.80M
13.18%
-235.90M
融资净额
161.63%
122.40M
-1482.52%
-1.48B
231.73%
98.40M
-1391.42%
-956.00M
-313.75%
-198.60M
91.22%
-93.80M
19.50%
-74.70M
-943.42%
-64.10M
-294.33%
-48.00M
-2297.53%
-1.07B
-267.21%
-92.80M
8.57%
7.60M
3.35%
24.70M
541.82%
48.60M
640.00%
55.50M
-57.83%
7.00M
125.47%
23.90M
-208.91%
-11.00M
22.95%
7.50M
196.43%
16.60M
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
United Therapeutics Corp的总收入是多少?
根据United Therapeutics Corp的FY2025财报,总收入达到了3.18B(同比变化2.88B)。
United Therapeutics Corp的流动资产是多少?
根据United Therapeutics Corp的FY2025财报,流动资产为3.70B(同比变化-4.42)。
United Therapeutics Corp的总资产是多少?
根据United Therapeutics Corp的FY2025财报,United Therapeutics Corp的总资产为7.88B(同比变化7.01)。
United Therapeutics Corp的总负债是多少?
根据United Therapeutics Corp的FY2025财报,United Therapeutics Corp的总负债为783.80M(同比变化-14.80)。
United Therapeutics Corp的总权益是多少?
根据United Therapeutics Corp的FY2025财报,United Therapeutics Corp的总权益为7.10B(同比变化10.12)。
United Therapeutics Corp的净营业收入是多少?
根据United Therapeutics Corp的FY2025财报,United Therapeutics Corp的净营业收入为1.52B(同比变化4.77)。
United Therapeutics Corp的净投资是多少?
根据United Therapeutics Corp的FY2025财报,United Therapeutics Corp的净投资为-551.30M(同比变化-232.14)。
United Therapeutics Corp的净融资是多少?
根据United Therapeutics Corp的FY2025财报,United Therapeutics Corp的净融资为-1.15B(同比变化8.35)。
United Therapeutics Corp的每股收益(EPS)是多少?
根据United Therapeutics Corp的FY2025财报,每股收益(EPS)为30.13(同比变化13.95)。
United Therapeutics Corp的净利润是多少?
根据United Therapeutics Corp的FY2025财报,净利润为1.33B(同比变化11.68)。
United Therapeutics Corp的净利润率是多少?
根据United Therapeutics Corp的FY2025财报,净利润率为41.94(同比变化0.97)。
United Therapeutics Corp的毛利率是多少?
根据United Therapeutics Corp的FY2025财报,毛利率为87.92(同比变化-1.47)。
United Therapeutics Corp的股东权益回报率(ROE)是多少?
根据United Therapeutics Corp的FY2025财报,股东权益回报率(ROE)为19.71(同比变化2.51)。
United Therapeutics Corp的资产回报率(ROA)是多少?
根据United Therapeutics Corp的FY2025财报,资产回报率(ROA)为17.51(同比变化6.46)。
United Therapeutics Corp的营业利润是多少?
根据United Therapeutics Corp的FY2025财报,营业利润为1.52B(同比变化4.77)。